286 related articles for article (PubMed ID: 21586746)
1. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
Miller WP; Rothman SM; Nascene D; Kivisto T; DeFor TE; Ziegler RS; Eisengart J; Leiser K; Raymond G; Lund TC; Tolar J; Orchard PJ
Blood; 2011 Aug; 118(7):1971-8. PubMed ID: 21586746
[TBL] [Abstract][Full Text] [Related]
2. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
[TBL] [Abstract][Full Text] [Related]
3. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
[TBL] [Abstract][Full Text] [Related]
4. Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy.
Chiesa R; Boelens JJ; Duncan CN; Kühl JS; Sevin C; Kapoor N; Prasad VK; Lindemans CA; Jones SA; Amartino HM; Algeri M; Bunin N; Diaz-de-Heredia C; Loes DJ; Shamir E; Timm A; McNeil E; Dietz AC; Orchard PJ
Blood Adv; 2022 Mar; 6(5):1512-1524. PubMed ID: 34781360
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation in patients with childhood cerebral adrenoleukodystrophy: A single-center experience "Better prognosis in earlier stage".
Yalcin K; Çelen SS; Daloglu H; Demir MK; Öztürkmen S; Pasayev D; Zhumatayev S; Uygun V; Hazar V; Karasu G; Yesilipek A
Pediatr Transplant; 2021 Jun; 25(4):e14015. PubMed ID: 33780114
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
7. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.
Peters C; Charnas LR; Tan Y; Ziegler RS; Shapiro EG; DeFor T; Grewal SS; Orchard PJ; Abel SL; Goldman AI; Ramsay NK; Dusenbery KE; Loes DJ; Lockman LA; Kato S; Aubourg PR; Moser HW; Krivit W
Blood; 2004 Aug; 104(3):881-8. PubMed ID: 15073029
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.
Kühl JS; Suarez F; Gillett GT; Hemmati PG; Snowden JA; Stadler M; Vuong GL; Aubourg P; Köhler W; Arnold R
Brain; 2017 Apr; 140(4):953-966. PubMed ID: 28375456
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
10. Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant.
Beckmann NB; Miller WP; Dietrich MS; Orchard PJ
Child Neuropsychol; 2018 Oct; 24(7):986-998. PubMed ID: 28934891
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
[TBL] [Abstract][Full Text] [Related]
12. Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
Mallhi K; Orchard PJ; Miller WP; Cao Q; Tolar J; Lund TC
Bone Marrow Transplant; 2017 May; 52(5):726-732. PubMed ID: 28092353
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
15. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
[TBL] [Abstract][Full Text] [Related]
16. Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.
Miller WP; Mantovani LF; Muzic J; Rykken JB; Gawande RS; Lund TC; Shanley RM; Raymond GV; Orchard PJ; Nascene DR
AJNR Am J Neuroradiol; 2016 Feb; 37(2):367-72. PubMed ID: 26427835
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
[TBL] [Abstract][Full Text] [Related]
20. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.
Bartelink IH; Lalmohamed A; van Reij EM; Dvorak CC; Savic RM; Zwaveling J; Bredius RG; Egberts AC; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Théorêt Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Güngör T; Wynn RF; Veys P; Cuvelier GD; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ
Lancet Haematol; 2016 Nov; 3(11):e526-e536. PubMed ID: 27746112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
